Piramal Pharma Q2 Results
- BSE: 543635
- NSE: PPLPHARMA
- ISIN: INE0DK501011
- Sector: -
BSE
249.75
-0.15 (-0.06%)
-0.15 (-0.06%)Volume2.52 L
Updated: Mon 25 Nov, 2024 | 15:29:47
NSE
250.3
0.15 (0.06%)
0.15 (0.06%)Volume4.05 M
Updated: Mon 25 Nov, 2024 | 15:41:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹2,241.75 Cr.(14.89%)
- Operating Profit₹754.64 Cr.(41.83%)
- Profit After Tax₹22.59 Cr.(NA%)
- Operating Margin33.66%(3.40%)
Note: Comparison is on YoY basis
Quarterly - Piramal Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2,241.75 | 1,748.85 | -% | 1,911.38 | -% |
| Selling/ General/ Admin Expenses Total | 559.53 | 495.54 | -% | 516.03 | -% |
| Depreciation/ Amortization | 192.22 | 173.61 | -% | 184.51 | -% |
| Other Operating Expenses Total | -61.11 | -38.31 | -% | -49.19 | -% |
| Total Operating Expense | 1,487.11 | 1,257.57 | -% | 1,289.08 | -% |
| Operating Income | 754.64 | 491.28 | -% | 622.30 | -% |
| Net Income Before Taxes | 120.12 | -107.11 | -% | 39.56 | -% |
| Net Income | 22.59 | -98.58 | -% | 5.02 | -% |
| Diluted Normalized EPS | 0.17 | -0.83 | -% | 0.04 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST